![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
An Analysis of Minor Variants in HIV-1 Integrase (IN) for Subjects With Only Historic Evidence of Integrase Inhibitor (INI) Resistance Enrolled in Study ING112574 (VIKING-3) (slide presentation, poster to follow)
|
|
|
Reported by Jules Levin
International Workshop on Antiviral Drug Resistance
June 3-7 2014, Berlin, Germany
R Paredes,1 M Noguera-Julian,1 C Pou,1 J Horton,2
K Remlinger,2 C Vavro2
1IrsiCaixa AIDS Research Institute and HIV Unit, Hospital Germans Trias i Pujol, Catalonia, Spain; 2GlaxoSmithKline, Research Triangle Park, NC, USA
![resist1.gif](../images/060614/060614-2/resist1.gif)
![resist2.gif](../images/060614/060614-2/resist2.gif)
![resist3.gif](../images/060614/060614-2/resist3.gif)
![resist4.gif](../images/060614/060614-2/resist4.gif)
![resist5.gif](../images/060614/060614-2/resist5.gif)
![resist6.gif](../images/060614/060614-2/resist6.gif)
![resist7.gif](../images/060614/060614-2/resist7.gif)
![resist8.gif](../images/060614/060614-2/resist8.gif)
![resist9.gif](../images/060614/060614-2/resist9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|